ECP 2022 Final Programme

Tuesday, 6 Sept 52 Scientific Programme a Tuesday e Tuesday, 6 September 2022 SC-10 Short Course 08:30–12:00 San Francisco Uropathology: A new landscape of molecular biomarkers for GU tumours Chairs: Dilek Ertoy Baydar, Turkey George Netto, USA 001 08:30–08:50 Precision pathology: journey of transforma- tion and innovative disruption George Netto, USA 002 08:50–09:10 BRCA1 and 2 and novel genetic markers in PCA Antonio Lopez-Beltran, Spain 003 09:10–09:30 Immunotherapy in bladder cancer: the role of the pathologist according to an oncologist Andrea Necchi, Italy 004 10:30–10:50 Emerging role of RNA modification in GU tract with emphasis on testis tumours João Lobo, Portugal 005 10:50–11:10 Circulating tumour cells: the role in the daily practice Arndt Hartmann, Germany 006 11:10–12:00 Q&A SPEC-06 Special Session 08:30–12:00 Singapore Special Session ESP QA: Good results come from experience, experience comes from bad results Chairs: Aleš Ryška, Czech Republic Nicola Normanno, Italy 001 08:30–08:50 Biomarker assay comparison for proficiency testing, validation, and interchangeability studies: how to do it right Emina Emilia Torlakovic, Canada 002 08:50–09:10 Benefits and challenges of a microsco- py-based EQA programme: experiences from the ESP lung scheme Jan von der Thüsen, The Netherlands 003 09:10–09:30 Experiences and lessons-learned from the molecular ESP lung scheme Ed Schuuring, The Netherlands 004 10:30–10:50 Lessons learnt from the first EQA of tumour mutation burden testing Simon Patton, United Kingdom 005 10:50–11:10 cfDNA testing – challenging the labs and challenging the EQA providers Sandi Deans, United Kingdom 006 11:10–11:30 Access and quality of biomarker testing in Europe Nicola Normanno, Italy 007 11:30–12:00 Q&A OFP-09 Oral Free Paper Session 08:30–12:00 Sydney Joint Oral Free Paper Session Endocrine Pathology / Head and Neck Pathology Chairs: Catarina Eloy, Portugal Stephan Ihrler, Germany 001 08:30–08:40 Cadherin-16 (CDH16) immunohistochemis- try: a novel diagnostic tool for renal cell carcinoma and papillary carcinomas of the thyroid Maximilian Lennartz, Germany S. Minner, N. Gorbokon, A. Menz, T. Krech, D. Höflmayer, R. Simon, G. Sauter, T. Clauditz, A. Hinsch 002 08:40–08:50 Pediatric thyroid nodules: a multi-institu- tional study from India based on the applicability of the Bethesda System with analysis of the Risk Of Malignancy (ROM) and comparison with adult thyroid nodules Chanchal Rana, India N. Nigam, S. Agarwal, P. Mishra, A. Bychkov